J. J. Finkelstein

Insider Reports History

Entity
Individual
Signature
/s/ Andrew Nick as Attorney-in-Fact for J.J. Finkelstein pursuant to Power of Attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by J. J. Finkelstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Common Stock 1.71M May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Stock Option (Right to Buy) 600K May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Convertible Promissory Note (right to buy) 20.9K May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Common Stock Warrant (right to buy) 0 May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Series A Common Stock Warrant (right to buy) 0 May 17, 2022 Direct
REGENERX BIOPHARMACEUTICALS INC President and CEO, Director Series B Common Stock Warrant (right to buy) 0 May 17, 2022 Direct

Insider Reports Filed by J. J. Finkelstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGRX REGENERX BIOPHARMACEUTICALS INC May 17, 2022 1 $0 4 May 19, 2022 President and CEO, Director
RGRX REGENERX BIOPHARMACEUTICALS INC Aug 2, 2021 1 $0 4 Aug 4, 2021 President and CEO, Director
RGRX REGENERX BIOPHARMACEUTICALS INC Jun 30, 2021 3 $15K 4 Jul 6, 2021 President and CEO, Director